相关实验视频

Updated: May 10, 2025

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

谷氨酸的双刃剑:促进瘤生长,提供治疗希望

Liguang Fang¹, Dandan Gao², Zuomin Jiang²

¹College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.

Frontiers in immunology

|April 25, 2025

概括

瘤细胞重新编程谷氨胺代谢以求生存和免疫逃避. 向谷氨胺代谢提供了新的癌症疗法,但抗性等挑战仍然存在.

科学领域:

在瘤学瘤学.
癌症新陈代谢癌症新陈代谢
免疫学免疫学免疫学

背景情况:

瘤代谢重编程对于在营养压力下癌细胞生存至关重要.
重编程谷氨酸代谢可以增强瘤生长,转移和耐药性.
谷氨胺代谢也影响瘤免疫微环境,在癌症进展中发挥双重作用.

研究的目的:

系统地审查关于瘤中的谷氨酸代谢重编程的最新研究.
探索谷氨胺代谢在瘤生长,扩散和免疫调节中的作用.
检查针对癌症的氨酸胺治疗的临床进展和挑战.

主要方法:

对癌症中的谷氨胺代谢最近研究的系统文献综述.
对谷氨酸对瘤生长,转移和免疫微环境的影响研究的分析.
对临床试验和针对谷氨胺向疗法和耐药机制的研究进行审查.

主要成果:

谷氨酸代谢重编程是癌症的一个关键标志,影响瘤进展和免疫逃避.
虽然经常促进癌症,但谷氨酸可以通过调节免疫微环境来抑制特定癌症 (例如胰腺癌,黑色素瘤) 的增殖.
向性谷氨胺疗法显示出希望,但面临与治疗耐药性相关的挑战.

结论:

了解谷氨胺代谢的重编程对于癌症发病和开发新疗法至关重要.
向谷氨胺代谢是一种有前途的治疗策略,通常与现有治疗相结合.
解决耐药机制对于成功临床应用谷氨胺向癌症疗法至关重要.

关键词:

组合疗法治疗组合治疗.谷氨胺的代谢过程免疫微观环境免疫微环境代谢重编程是指代谢重编程.这些都是瘤,瘤.

更多相关视频

Evaluation of Amino Acid Consumption in Cultured Bone Cells and Isolated Bone Shafts

Evaluation of Amino Acid Consumption in Cultured Bone Cells and Isolated Bone Shafts

Published on: April 13, 2022

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...